Contact us

Author: Diana

Zymeworks Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer Annual Meeting

We are excited to announce two poster presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting, taking place November 5-9, 2025, in National Harbor, MD. Presentation Details Title: Design of a Next Generation Tumor Targeted Masked IL-12Fc for Enhanced Tolerability and Localized Anti-Tumor Activity Abstract Number: 853 Date: November 7 Category: Immune-Stimulants […]

Zymeworks Presents Preclinical Data on ZW1528 at the European Respiratory Society Annual Congress

We are pleased to present preclinical data for ZW1528, a novel IL-4Rα x IL-33 bispecific molecule designed to address respiratory inflammation, at the at European Respiratory Society (ERS) Congress 2025, taking place September 27 – October 1, 2025, in Amsterdam, Netherlands and virtually. The poster presentation titled “ZW1528, a Bispecific Antibody Targeting IL-4Rα and IL-33, […]

Zymeworks Announces Presentation at the European Respiratory Society (ERS) Congress 2025

Zymeworks is attending and presenting at European Respiratory Society (ERS) Congress 2025, taking place September 27 – October 1, 2025, in Amsterdam, Netherlands and virtually. Presentation details: Abstract Title: ZW1528: A dual-targeting bispecific antibody to broadly suppress airway inflammation by inhibiting IL-4Ra and IL-33 pathways Poster Number: PA4587 Presenter: Blair K. Hardman, Ph.D. Session#391: Biologics […]

Zymeworks Wins Life Sciences BC 2025 Company of the Year Award

We are pleased to announce that Zymeworks has received Life Sciences BC’s 2025 Company of the Year Award! The award is presented to an outstanding company for its leadership and achievements that are significantly strengthening the BC life sciences sector. It recognizes strong overall performance, excellent execution of business strategies, effective leadership following a clear […]